Rps6ka5 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA CTD PMID:22079256 Rps6ka5 Rat 1,2-dimethylhydrazine decreases expression ISO Rps6ka5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of RPS6KA5 mRNA CTD PMID:22206623 Rps6ka5 Rat 1-chloro-2,4-dinitrobenzene affects binding ISO RPS6KA5 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to RPS6KA5 protein CTD PMID:32991956 Rps6ka5 Rat 17beta-estradiol multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA CTD PMID:17404688 Rps6ka5 Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 2 more ... CTD PMID:36804509 Rps6ka5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPS6KA5 mRNA CTD PMID:19933214 Rps6ka5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RPS6KA5 mRNA CTD PMID:34747641 Rps6ka5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [RPS6KA5 protein binds to CYP1A1 enhancer] CTD PMID:24519526 Rps6ka5 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Rps6ka5 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of RPS6KA5 mRNA CTD PMID:25172293 Rps6ka5 Rat 3,4-methylenedioxymethamphetamine decreases expression ISO Rps6ka5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of RPS6KA5 mRNA CTD PMID:26251327 Rps6ka5 Rat 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of RPS6KA5 mRNA CTD PMID:30071829 Rps6ka5 Rat 3,4-methylenedioxymethamphetamine decreases methylation ISO Rps6ka5 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased methylation of RPS6KA5 promoter CTD PMID:26251327 Rps6ka5 Rat 4,4'-diaminodiphenylmethane increases expression ISO Rps6ka5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of RPS6KA5 mRNA CTD PMID:18648102 Rps6ka5 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Rps6ka5 (Mus musculus) 6480464 bisphenol S results in decreased methylation of RPS6KA5 promoter CTD PMID:33297965 Rps6ka5 Rat 4-hydroxyphenyl retinamide decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Fenretinide results in decreased expression of RPS6KA5 mRNA CTD PMID:28973697 Rps6ka5 Rat all-trans-retinoic acid decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of RPS6KA5 mRNA CTD PMID:33167477 Rps6ka5 Rat aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of RPS6KA5 protein CTD PMID:38428544 Rps6ka5 Rat arsenite(3-) increases activity ISO Rps6ka5 (Mus musculus) 6480464 arsenite results in increased activity of RPS6KA5 protein CTD PMID:11689710 Rps6ka5 Rat avermectin decreases phosphorylation ISO RPS6KA5 (Homo sapiens) 6480464 avermectin results in decreased phosphorylation of RPS6KA5 protein CTD PMID:33381906 Rps6ka5 Rat benzene increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Benzene results in increased expression of RPS6KA5 mRNA CTD PMID:33064461 Rps6ka5 Rat benzo[a]pyrene decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of RPS6KA5 mRNA CTD PMID:22228805 Rps6ka5 Rat benzo[a]pyrene affects methylation ISO RPS6KA5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of RPS6KA5 3' UTR CTD PMID:27901495 Rps6ka5 Rat benzo[a]pyrene multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Benzo(a)pyrene promotes the reaction [TNF protein results in increased expression of RPS6KA5 protein modified form]] and Benzo(a)pyrene promotes the reaction [TNF protein results in increased expression of RPS6KA5 protein modified form] CTD PMID:25233930 Rps6ka5 Rat beta-naphthoflavone decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of RPS6KA5 mRNA CTD PMID:32858204 Rps6ka5 Rat bis(2-chloroethyl) sulfide decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Mustard Gas results in decreased expression of RPS6KA5 mRNA CTD PMID:18955075 Rps6ka5 Rat bis(2-chloroethyl) sulfide increases phosphorylation ISO Rps6ka5 (Mus musculus) 6480464 Mustard Gas results in increased phosphorylation of RPS6KA5 protein CTD PMID:18200059 Rps6ka5 Rat bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of RPS6KA5 mRNA CTD PMID:35810816 Rps6ka5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RPS6KA5 mRNA CTD PMID:25181051 more ... Rps6ka5 Rat bisphenol A increases expression ISO Rps6ka5 (Mus musculus) 6480464 bisphenol A results in increased expression of RPS6KA5 mRNA CTD PMID:35598803 Rps6ka5 Rat bisphenol A increases methylation ISO RPS6KA5 (Homo sapiens) 6480464 bisphenol A results in increased methylation of RPS6KA5 gene CTD PMID:31601247 Rps6ka5 Rat cadmium dichloride increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of RPS6KA5 mRNA CTD PMID:38382870 Rps6ka5 Rat calcitriol decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of RPS6KA5 mRNA CTD PMID:16002434 Rps6ka5 Rat cannabidiol increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Cannabidiol results in increased expression of RPS6KA5 mRNA CTD PMID:27918106 Rps6ka5 Rat chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of RPS6KA5 mRNA CTD PMID:23125180 Rps6ka5 Rat cocaine increases expression EXP 6480464 Cocaine results in increased expression of RPS6KA5 mRNA and Cocaine results in increased expression of RPS6KA5 protein CTD PMID:17898221 and PMID:25100957 Rps6ka5 Rat cocaine affects response to substance ISO Rps6ka5 (Mus musculus) 6480464 RPS6KA5 affects the susceptibility to Cocaine CTD PMID:16339038 Rps6ka5 Rat cocaine increases activity ISO Rps6ka5 (Mus musculus) 6480464 Cocaine results in increased activity of RPS6KA5 protein CTD PMID:16339038 Rps6ka5 Rat cocaine multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein and SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] CTD PMID:16339038 Rps6ka5 Rat copper atom multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of RPS6KA5 mRNA CTD PMID:30911355 Rps6ka5 Rat copper(0) multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of RPS6KA5 mRNA CTD PMID:30911355 Rps6ka5 Rat cyclosporin A increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of RPS6KA5 mRNA CTD PMID:20106945 Rps6ka5 Rat decabromodiphenyl ether increases expression ISO RPS6KA5 (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of RPS6KA5 protein CTD PMID:31675489 Rps6ka5 Rat deoxynivalenol increases phosphorylation ISO Rps6ka5 (Mus musculus) 6480464 deoxynivalenol results in increased phosphorylation of RPS6KA5 protein CTD PMID:16424113 Rps6ka5 Rat Dibutyl phosphate affects expression ISO RPS6KA5 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of RPS6KA5 mRNA CTD PMID:37042841 Rps6ka5 Rat diclofenac decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Diclofenac results in decreased expression of RPS6KA5 mRNA CTD PMID:26934552 Rps6ka5 Rat dorsomorphin multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS6KA5 mRNA CTD PMID:27188386 Rps6ka5 Rat doxorubicin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of RPS6KA5 mRNA CTD PMID:29803840 Rps6ka5 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of RPS6KA5 mRNA CTD PMID:29391264 Rps6ka5 Rat ethyl methanesulfonate increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of RPS6KA5 mRNA CTD PMID:23649840 Rps6ka5 Rat fasudil decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 fasudil results in decreased activity of RPS6KA5 protein CTD PMID:10998351 Rps6ka5 Rat fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of RPS6KA5 mRNA CTD PMID:30307764 Rps6ka5 Rat folic acid decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Folic Acid results in decreased expression of RPS6KA5 mRNA CTD PMID:25629700 Rps6ka5 Rat formaldehyde increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of RPS6KA5 mRNA CTD PMID:23649840 Rps6ka5 Rat FR900359 affects phosphorylation ISO RPS6KA5 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of RPS6KA5 protein CTD PMID:37730182 Rps6ka5 Rat gallic acid multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of RPS6KA5 protein] CTD PMID:21420233 Rps6ka5 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RPS6KA5 mRNA CTD PMID:33387578 Rps6ka5 Rat hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of RPS6KA5 promoter CTD PMID:23740543 Rps6ka5 Rat hydralazine multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA CTD PMID:17183730 Rps6ka5 Rat hydrogen peroxide increases activity ISO Rps6ka5 (Mus musculus) 6480464 Hydrogen Peroxide results in increased activity of RPS6KA5 protein CTD PMID:11689710 Rps6ka5 Rat ivermectin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of RPS6KA5 protein CTD PMID:32959892 Rps6ka5 Rat MeIQx increases expression ISO RPS6KA5 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 Rps6ka5 Rat metformin multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Metformin co-treated with Pioglitazone] results in decreased expression of RPS6KA5 mRNA CTD PMID:32589349 Rps6ka5 Rat metformin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Metformin results in decreased expression of RPS6KA5 mRNA CTD PMID:32589349 Rps6ka5 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of RPS6KA5 gene CTD PMID:35440735 Rps6ka5 Rat methyl methanesulfonate increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of RPS6KA5 mRNA CTD PMID:23649840 Rps6ka5 Rat mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of RPS6KA5 mRNA CTD PMID:25972201 Rps6ka5 Rat ML-7 decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 ML 7 results in decreased activity of RPS6KA5 protein CTD PMID:12534346 Rps6ka5 Rat N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA5 protein CTD PMID:10998351 and PMID:18377872 Rps6ka5 Rat N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide decreases activity EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA5 protein CTD PMID:15522277 Rps6ka5 Rat nickel sulfate increases expression ISO RPS6KA5 (Homo sapiens) 6480464 nickel sulfate results in increased expression of RPS6KA5 mRNA CTD PMID:22714537 Rps6ka5 Rat niclosamide increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Niclosamide results in increased expression of RPS6KA5 mRNA CTD PMID:36318118 Rps6ka5 Rat Nor-9-carboxy-delta9-THC multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of RPS6KA5 gene CTD PMID:30521419 Rps6ka5 Rat obeticholic acid decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of RPS6KA5 mRNA CTD PMID:27939613 Rps6ka5 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RPS6KA5 mRNA CTD PMID:25729387 Rps6ka5 Rat oxidopamine multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 [benserazide more ... CTD PMID:17596448 and PMID:19187092 Rps6ka5 Rat ozone multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of RPS6KA5 mRNA CTD PMID:35430440 Rps6ka5 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of RPS6KA5 mRNA CTD PMID:33387578 Rps6ka5 Rat paraquat increases expression ISO Rps6ka5 (Mus musculus) 6480464 Paraquat results in increased expression of RPS6KA5 mRNA CTD PMID:28012437 Rps6ka5 Rat phenylephrine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] more ... CTD PMID:15522277 and PMID:19002563 Rps6ka5 Rat pioglitazone multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Metformin co-treated with Pioglitazone] results in decreased expression of RPS6KA5 mRNA CTD PMID:32589349 Rps6ka5 Rat pirinixic acid multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KA5 mRNA CTD PMID:19710929 Rps6ka5 Rat potassium chromate multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RPS6KA5 mRNA CTD PMID:22079256 Rps6ka5 Rat potassium chromate decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of RPS6KA5 mRNA CTD PMID:22079256 Rps6ka5 Rat progesterone multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of RPS6KA5 mRNA CTD PMID:17404688 Rps6ka5 Rat quercetin increases phosphorylation ISO RPS6KA5 (Homo sapiens) 6480464 Quercetin results in increased phosphorylation of RPS6KA5 protein CTD PMID:18377872 Rps6ka5 Rat quercetin multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased phosphorylation of RPS6KA5 protein] CTD PMID:18377872 Rps6ka5 Rat Ro 31-8220 decreases activity EXP 6480464 Ro 31-8220 results in decreased activity of RPS6KA5 protein CTD PMID:15522277 Rps6ka5 Rat SB 203580 multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [U 0126 co-treated with SB 203580] inhibits the reaction [sodium arsenite results in increased activity of RPS6KA5 protein] and SB 203580 inhibits the reaction [sodium arsenite results in increased activity of RPS6KA5 protein] CTD PMID:12547826 Rps6ka5 Rat SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Phenylephrine results in increased phosphorylation of and results in increased activity of RPS6KA5 protein] CTD PMID:15522277 Rps6ka5 Rat SB 431542 multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS6KA5 mRNA CTD PMID:27188386 Rps6ka5 Rat SCH 23390 multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 SCH 23390 inhibits the reaction [[Oxidopamine co-treated with Levodopa] results in increased expression of RPS6KA5 protein] CTD PMID:19187092 Rps6ka5 Rat silicon dioxide increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of RPS6KA5 mRNA CTD PMID:25895662 Rps6ka5 Rat silicon dioxide decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of RPS6KA5 mRNA CTD PMID:29203145 Rps6ka5 Rat silver atom decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Silver results in decreased expression of RPS6KA5 mRNA CTD PMID:27131904 Rps6ka5 Rat silver(0) decreases expression ISO Rps6ka5 (Mus musculus) 6480464 Silver results in decreased expression of RPS6KA5 mRNA CTD PMID:27131904 Rps6ka5 Rat SL-327 multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 SL 327 inhibits the reaction [[benserazide more ... CTD PMID:16339038 and PMID:17596448 Rps6ka5 Rat sodium arsenite multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [U 0126 co-treated with SB 203580] inhibits the reaction [sodium arsenite results in increased activity of RPS6KA5 protein] more ... CTD PMID:12547826 Rps6ka5 Rat sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of RPS6KA5 mRNA CTD PMID:35314868 Rps6ka5 Rat sodium arsenite decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of RPS6KA5 mRNA CTD PMID:28595984 and PMID:34032870 Rps6ka5 Rat sodium arsenite increases activity ISO RPS6KA5 (Homo sapiens) 6480464 sodium arsenite results in increased activity of RPS6KA5 protein CTD PMID:12547826 Rps6ka5 Rat succimer multiple interactions ISO Rps6ka5 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA CTD PMID:21641980 Rps6ka5 Rat sunitinib increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Sunitinib results in increased expression of RPS6KA5 mRNA CTD PMID:31533062 Rps6ka5 Rat T-2 toxin decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 T-2 Toxin results in decreased expression of RPS6KA5 mRNA CTD PMID:34581912 Rps6ka5 Rat temozolomide increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Temozolomide results in increased expression of RPS6KA5 mRNA CTD PMID:31758290 Rps6ka5 Rat titanium dioxide decreases methylation ISO Rps6ka5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of RPS6KA5 gene CTD PMID:35295148 Rps6ka5 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RPS6KA5 mRNA CTD PMID:25729387 Rps6ka5 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of RPS6KA5 mRNA CTD PMID:25729387 Rps6ka5 Rat trichostatin A increases expression ISO RPS6KA5 (Homo sapiens) 6480464 trichostatin A results in increased expression of RPS6KA5 mRNA CTD PMID:24935251 and PMID:26272509 Rps6ka5 Rat trichostatin A multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPS6KA5 mRNA CTD PMID:27188386 Rps6ka5 Rat triphenyl phosphate affects expression ISO RPS6KA5 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of RPS6KA5 mRNA CTD PMID:37042841 Rps6ka5 Rat urethane increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Urethane results in increased expression of RPS6KA5 mRNA CTD PMID:28818685 Rps6ka5 Rat valproic acid multiple interactions ISO RPS6KA5 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of RPS6KA5 mRNA CTD PMID:17183730 Rps6ka5 Rat valproic acid decreases methylation ISO RPS6KA5 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of RPS6KA5 gene CTD PMID:28853863 more ... Rps6ka5 Rat valproic acid increases expression ISO RPS6KA5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of RPS6KA5 mRNA CTD PMID:29154799 Rps6ka5 Rat valproic acid decreases expression ISO RPS6KA5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of RPS6KA5 mRNA CTD PMID:23179753 and PMID:28001369 Rps6ka5 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of RPS6KA5 mRNA CTD PMID:18042343 Rps6ka5 Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of RPS6KA5 mRNA CTD PMID:19015723 Rps6ka5 Rat Y-27632 decreases activity ISO RPS6KA5 (Homo sapiens) 6480464 Y 27632 results in decreased activity of RPS6KA5 protein CTD PMID:10998351